AMBER Study: Phase 3 Symtuza Results
At the 16th European AIDS Conference in Milan, Italy, on October 25, 2017, Janssen Pharmaceutica, NV announced the results of its Phase 3 AMBER...
Undetectable = Untransmittable Reconfirmed by New Study, Embraced at IAS 2017
A newly completed study of 358 serodiscordant gay couples has not found a single case of HIV transmission in 16,889 acts of condomless anal...
CDC Announces: More people with HIV have the virus under control
On July 26, 2017, the Centers for Disease Control and Prevention released new data on the nation’s progress in HIV testing and treatment, showing...
SMYD2 & the HIV Reservoir
Shock Value
Research on SMYD2 shows potential to wake up the HIV reservoir
by Chael Needle
HIV latency—where HIV hides out in reservoirs, dormant and beyond the...
Restoring Immune Balance
Chronic inflammation means the immune system is imbalanced—a natural immune response has persisted, or immune regulation is not working properly. Research has shown that...
Fast-Tracked or Foiled?
Last month, the Member States of the United Nations adopted the “Political Declaration on HIV and AIDS: On the Fast-Track to Accelerate the Fight...
PRO 140
Chronic Relief?
A self-injectable monoclonal antibody vies to become a monotherapy
by Chael Needle
Anti-HIV agents currently being researched these days seem split between (1) improving regimens...
Long-Term Survivors: More Than Surviving
More Than Surviving
A new report calls for aging well with HIV
by Chael Needle
More than half of the 1.2 million people living with HIV in...
Women’s HIV Program: Empowerment Is Treatment
Undetectable is a worthy goal, no doubt about it. A suppressed viral load very often means the individual living with HIV is adherent to...
REPRIEVE Study
Protecting One's Heart
The REPRIEVE study aims to prevent cardiovascular disease
by Chael Needle
As people are living longer with HIV, researchers have been increasingly attending to...
LATEST POSTS
Reaserching a Monthly Pill for PrEP for Cis Women
Researchers Receive $122 Million to Study Monthly Pill for PrEP
The University of Washington School of Medicine announced that it has received $122 million from...
